Idexx Laboratories Stock Probability Of Bankruptcy

IDXX Stock

USD 421.75 0.01 0%

IDEXX Laboratories' odds of distress is below 1% at this time. The company is very unlikely to encounter any financial hardship in the next two years. Probability of bankruptcy shows the probability of financial torment over the next two years of operations under current economic and market conditions. All items used in analyzing the odds of distress are taken from the IDEXX balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out IDEXX Laboratories Piotroski F Score and IDEXX Laboratories Altman Z Score analysis.

For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

Market Cap is likely to rise to about 7 B in 2024. Enterprise Value is likely to rise to about 7.6 B in 2024

IDEXX Laboratories Company probability of bankruptcy Analysis

IDEXX Laboratories' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current IDEXX Laboratories Probability Of Bankruptcy

Less than 1%

Most of IDEXX Laboratories' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IDEXX Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Our calculation of IDEXX Laboratories probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting IDEXX Laboratories odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of IDEXX Laboratories financial health.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.107

Earnings Share

10.38

Revenue Per Share

46.447

Quarterly Revenue Growth

0.066

Return On Assets

0.2279

The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

IDEXX Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for IDEXX Laboratories is extremely important. It helps to project a fair market value of IDEXX Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since IDEXX Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of IDEXX Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of IDEXX Laboratories' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Common Stock	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Good Will	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.73	0.49	0.91	0.95	0.98	0.82	0.96	0.72	0.14	0.54	-0.89	0.98	0.6	0.8	0.62	0.05	0.72	0.85	-0.53	-0.46	0.79	0.71	0.7	0.69
Total Stockholder Equity	0.73		-0.22	0.89	0.59	0.74	0.2	0.69	0.61	-0.37	0.14	-0.56	0.68	0.09	0.5	0.0	0.52	0.14	0.47	-0.72	-0.44	0.77	0.79	0.8	0.73
Net Debt	0.49	-0.22		0.17	0.61	0.47	0.89	0.48	0.26	0.73	0.51	-0.5	0.53	0.64	0.49	0.82	-0.61	0.8	0.6	0.15	0.04	0.24	0.01	-0.08	0.09
Retained Earnings	0.91	0.89	0.17		0.84	0.92	0.55	0.83	0.76	-0.08	0.33	-0.84	0.88	0.42	0.74	0.33	0.33	0.45	0.73	-0.72	-0.44	0.87	0.76	0.71	0.74
Accounts Payable	0.95	0.59	0.61	0.84		0.96	0.86	0.87	0.74	0.18	0.53	-0.91	0.96	0.69	0.86	0.71	0.06	0.79	0.89	-0.55	-0.47	0.7	0.61	0.56	0.6
Net Receivables	0.98	0.74	0.47	0.92	0.96		0.79	0.91	0.72	0.07	0.46	-0.89	0.98	0.61	0.83	0.62	0.15	0.72	0.88	-0.65	-0.49	0.81	0.71	0.69	0.69
Total Liab	0.82	0.2	0.89	0.55	0.86	0.79		0.8	0.51	0.51	0.65	-0.8	0.84	0.78	0.72	0.89	-0.37	0.92	0.82	-0.16	-0.29	0.48	0.35	0.33	0.38
Total Current Assets	0.96	0.69	0.48	0.83	0.87	0.91	0.8		0.64	0.25	0.56	-0.78	0.91	0.48	0.69	0.57	-0.08	0.67	0.76	-0.34	-0.34	0.75	0.7	0.72	0.68
Intangible Assets	0.72	0.61	0.26	0.76	0.74	0.72	0.51	0.64		0.17	0.63	-0.8	0.67	0.39	0.84	0.32	0.34	0.37	0.61	-0.41	-0.24	0.57	0.51	0.3	0.35
Short Term Debt	0.14	-0.37	0.73	-0.08	0.18	0.07	0.51	0.25	0.17		0.48	-0.15	0.1	0.19	0.21	0.33	-0.75	0.3	0.18	0.56	0.61	0.11	-0.19	-0.42	-0.19
Common Stock	0.54	0.14	0.51	0.33	0.53	0.46	0.65	0.56	0.63	0.48		-0.64	0.52	0.61	0.66	0.56	-0.24	0.55	0.52	0.1	-0.19	0.1	0.16	0.08	-0.03
Treasury Stock	-0.89	-0.56	-0.5	-0.84	-0.91	-0.89	-0.8	-0.78	-0.8	-0.15	-0.64		-0.9	-0.79	-0.9	-0.69	-0.15	-0.73	-0.86	0.54	0.52	-0.59	-0.53	-0.47	-0.45
Property Plant Equipment	0.98	0.68	0.53	0.88	0.96	0.98	0.84	0.91	0.67	0.1	0.52	-0.9		0.69	0.81	0.68	0.03	0.77	0.89	-0.58	-0.53	0.76	0.66	0.66	0.67
Current Deferred Revenue	0.6	0.09	0.64	0.42	0.69	0.61	0.78	0.48	0.39	0.19	0.61	-0.79	0.69		0.74	0.89	-0.15	0.88	0.82	-0.32	-0.59	0.2	0.28	0.24	0.04
Good Will	0.8	0.5	0.49	0.74	0.86	0.83	0.72	0.69	0.84	0.21	0.66	-0.9	0.81	0.74		0.67	0.2	0.72	0.91	-0.51	-0.41	0.56	0.62	0.36	0.21
Long Term Debt	0.62	0.0	0.82	0.33	0.71	0.62	0.89	0.57	0.32	0.33	0.56	-0.69	0.68	0.89	0.67		-0.28	0.98	0.81	-0.16	-0.49	0.2	0.29	0.28	0.09
Net Tangible Assets	0.05	0.52	-0.61	0.33	0.06	0.15	-0.37	-0.08	0.34	-0.75	-0.24	-0.15	0.03	-0.15	0.2	-0.28		-0.26	0.01	-0.66	-0.43	0.11	0.33	0.32	0.16
Long Term Debt Total	0.72	0.14	0.8	0.45	0.79	0.72	0.92	0.67	0.37	0.3	0.55	-0.73	0.77	0.88	0.72	0.98	-0.26		0.88	-0.23	-0.52	0.33	0.43	0.4	0.2
Capital Surpluse	0.85	0.47	0.6	0.73	0.89	0.88	0.82	0.76	0.61	0.18	0.52	-0.86	0.89	0.82	0.91	0.81	0.01	0.88		-0.53	-0.5	0.62	0.69	0.51	0.3
Deferred Long Term Liab	-0.53	-0.72	0.15	-0.72	-0.55	-0.65	-0.16	-0.34	-0.41	0.56	0.1	0.54	-0.58	-0.32	-0.51	-0.16	-0.66	-0.23	-0.53		0.6	-0.6	-0.55	-0.56	-0.51
Short Long Term Debt	-0.46	-0.44	0.04	-0.44	-0.47	-0.49	-0.29	-0.34	-0.24	0.61	-0.19	0.52	-0.53	-0.59	-0.41	-0.49	-0.43	-0.52	-0.5	0.6		-0.08	-0.46	-0.68	-0.3
Long Term Investments	0.79	0.77	0.24	0.87	0.7	0.81	0.48	0.75	0.57	0.11	0.1	-0.59	0.76	0.2	0.56	0.2	0.11	0.33	0.62	-0.6	-0.08		0.67	0.55	0.73
Net Invested Capital	0.71	0.79	0.01	0.76	0.61	0.71	0.35	0.7	0.51	-0.19	0.16	-0.53	0.66	0.28	0.62	0.29	0.33	0.43	0.69	-0.55	-0.46	0.67		0.82	0.42
Net Working Capital	0.7	0.8	-0.08	0.71	0.56	0.69	0.33	0.72	0.3	-0.42	0.08	-0.47	0.66	0.24	0.36	0.28	0.32	0.4	0.51	-0.56	-0.68	0.55	0.82		0.69
Capital Stock	0.69	0.73	0.09	0.74	0.6	0.69	0.38	0.68	0.35	-0.19	-0.03	-0.45	0.67	0.04	0.21	0.09	0.16	0.2	0.3	-0.51	-0.3	0.73	0.42	0.69

Click cells to compare fundamentals

The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.

Competition

Predict IDEXX Laboratories

Based on the latest financial disclosure, IDEXX Laboratories has a Probability Of Bankruptcy of 1.0%. This is 97.69% lower than that of the Health Care Equipment & Supplies sector and 97.55% lower than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 97.49% higher than that of the company.

IDEXX Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IDEXX Laboratories' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IDEXX Laboratories could also be used in its relative valuation, which is a method of valuing IDEXX Laboratories by comparing valuation metrics of similar companies.

IDEXX Laboratories is currently under evaluation in probability of bankruptcy category among its peers.

IDEXX Laboratories Main Bankruptcy Drivers

	2019	2020	2021	2022	2023	2024 (projected)
Asset Turnover	1.15	1.44	1.31	1.32	1.23	0.86
Net Debt	897.3M	524.6M	779.2M	1.2B	613.4M	644.1M
Total Current Liabilities	725.3M	582.8M	763.6M	1.2B	951.5M	999.1M
Non Current Liabilities Total	929.3M	1.1B	983.6M	902.2M	823.8M	865.0M
Total Assets	1.8B	2.3B	2.4B	2.7B	3.3B	3.4B
Total Current Assets	679.6M	1.1B	955.7M	1.1B	1.5B	1.6B
Total Cash From Operating Activities	459.2M	648.1M	755.5M	543.0M	906.5M	951.8M

IDEXX Laboratories ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, IDEXX Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to IDEXX Laboratories' managers, analysts, and investors.

Environmental

Governance

Social

IDEXX Fundamentals

	Return On Equity	0.59
	Return On Asset	0.23
	Profit Margin	0.23 %
	Operating Margin	0.37 %
	Current Valuation	35.23 B
	Shares Outstanding	81.88 M
	Shares Owned By Insiders	0.94 %
	Shares Owned By Institutions	94.20 %
	Number Of Shares Shorted	1.62 M
	Price To Earning	61.31 X
	Price To Book	21.34 X
	Price To Sales	8.98 X
	Revenue	3.66 B
	Gross Profit	2 B
	EBITDA	1.1 B
	Net Income	845.04 M
	Cash And Equivalents	114.36 M
	Cash Per Share	1.37 X
	Total Debt	1.07 B
	Debt To Equity	3.27 %
	Current Ratio	0.89 X
	Book Value Per Share	19.72 X
	Cash Flow From Operations	906.51 M
	Short Ratio	2.06 X
	Earnings Per Share	10.38 X
	Price To Earnings To Growth	4.44 X
	Target Price	476.76
	Number Of Employees	11 K
	Beta	1.36
	Market Capitalization	34.53 B
	Total Asset	3.26 B
	Retained Earnings	4.44 B
	Working Capital	543.71 M
	Current Asset	821.63 M
	Current Liabilities	856.76 M
	Net Asset	3.26 B

About IDEXX Laboratories Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze IDEXX Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IDEXX Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IDEXX Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for IDEXX Stock Analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Idexx Laboratories Stock Probability Of Bankruptcy

IDEXX Laboratories Company probability of bankruptcy Analysis

Probability Of Bankruptcy

Normalized

Z-Score

Current IDEXX Laboratories Probability Of Bankruptcy

IDEXX Probability Of Bankruptcy Driver Correlations

IDEXX Probability Of Bankruptcy Peer Comparison

IDEXX Laboratories Main Bankruptcy Drivers

IDEXX Laboratories ESG Sustainability

IDEXX Fundamentals

About IDEXX Laboratories Fundamental Analysis

Also Currently Popular

Additional Tools for IDEXX Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY